BHST — BIOHARVEST SCIENCES INC.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1723464 ·
Last close
$1.50
Market Cap
$33.89M
52W High
$12.80
52W Low
$1.37
ADV30
32,860
Next earnings
2026-11-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 8,837,000 | 5,082,000 | -2,507,000 | -3,715,000 | 44,569,000 | 15,211,000 | 24,805,000 |
| Mar 2026 | 8,507,000 | 5,037,000 | -1,834,000 | -2,641,000 | 45,558,000 | 19,167,000 | 22,535,000 |
| Dec 2025 | 9,066,000 | 5,225,000 | -1,121,000 | -2,204,000 | 47,665,000 | 23,025,000 | 22,217,000 |
| Sep 2025 | 9,067,000 | 5,570,000 | -920,000 | -2,513,000 | 35,188,000 | 10,966,000 | 27,453,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-7,178,000
Investing CF
$-3,278,000
Financing CF
$26,225,000
CapEx
$-2,264,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.62
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-110,194,000
Inventory
$4,971,000
Receivables
$3,181,000
ST Investments
$1,001,000
EBIT TTM
$-8,337,000
Pretax Income TTM
$-11,354,000
Interest Exp TTM
$3,017,000
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$35,477,000
EBITDA
$-5,804,000
Free Cash Flow
$-11,845,250
Enterprise Value
$41,407,508
Total Cash
$16,223,000
Total Debt
$15,695,000
Shares Out
22,667,842
Trailing EPS
$-0.51
Book Value
$0.87
ROE
-142.5%
ROA
-11.0%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 34,508,000 | -5,575,000 | -11,135,000 | 47,665,000 | 22,217,000 | 25,448,000 | -7,226,000 |
| Dec 2024 | 25,188,000 | -6,989,000 | -12,913,000 | 25,001,000 | 23,671,000 | 1,330,000 | -6,684,000 |
| Dec 2023 | 12,672,000 | -9,966,000 | -12,564,000 | 15,002,000 | 29,855,000 | -14,853,000 | -8,522,000 |
| Dec 2022 | 5,498,000 | -10,612,000 | -11,236,000 | 9,393,000 | 15,322,000 | -5,929,000 | -9,241,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.34
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ATNM | Actinium Pharmaceuticals, Inc. | $33.96M | $1.08 | — |
| BCTX | BriaCell Therapeutics Corp. | $34.10M | $3.92 | — |
| NNVC | NANOVIRICIDES, INC. | $33.44M | $1.31 | — |
| EDSA | Edesa Biotech, Inc. | $35.29M | $3.66 | — |
| BETRF | BetterLife Pharma Inc. | $32.40M | $0.19 | — |
News headlines (Yahoo Finance, 1h cache)
BioHarvest says its platform can produce target sweetener in Tate & Lyle program
2026-10-08 13:37 · Yahoo
Tate & Lyle and Bioharvest Reach Key Milestone in Next-Generation Sweetener Development Programme
2026-10-08 12:00 · Yahoo
BioHarvest Sciences launches buyback of up to 5% of shares
2026-09-29 12:40 · Yahoo
BioHarvest Sciences Announces Share Repurchase Program
2026-09-29 11:00 · Yahoo
BioHarvest Sciences launches single-dose VINIA Daily Chews
2026-09-15 13:13 · Yahoo
BioHarvest Advances Botanical Synthesis Leadership as VINIA Daily Chews Unlock More Value from Its First Consumer Product
2026-09-15 11:00 · Yahoo
BioHarvest Sciences plans Tel Aviv Stock Exchange dual listing
2026-09-03 12:55 · Yahoo
BioHarvest Sciences Registers for Dual Listing on the Tel Aviv Stock Exchange (TASE)
2026-09-03 11:00 · Yahoo
BioHarvest Sciences (BHST) Q2 2026 Earnings Call Transcript
2026-08-12 01:57 · Yahoo
BioHarvest Sciences Inc (BHST) (Q2 2026) Earnings Call Highlights: Strategic Pivot to ...
2026-08-11 19:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.